Common antidepressants linked to dementia risk: Study

Image
IANS New York
Last Updated : Apr 27 2018 | 4:21 PM IST

If you are used to taking commonly prescribed antidepressants, think twice. According to a study, you may be at high risk of developing dementia, even 20 years before the actual diagnosis, a study has warned.

The researchers found greater incidence of dementia among patients prescribed anticholinergic antidepressants, anticholinergic bladder medications as well as anticholinergic Parkinson's disease medications than among older adults who were not prescribed these drugs.

"Anticholinergics, medications that block acetylcholine, a nervous system neurotransmitter, have previously been implicated as a potential cause of cognitive impairment," said Noll Campbell, assistant professor at the Purdue University in Indiana.

However, the researchers are yet not aware of "exactly how anticholinergics might cause dementia", the researchers said.

For the study, published in the journal BMJ, an international team from the US, UK and Ireland analysed more than 27 million prescriptions as recorded in the medical records of 40,770 patients over age 65 diagnosed with dementia compared to the records of 283,933 older adults without dementia.

"The findings make it clear that clinicians need to carefully consider the anticholinergic burden of their patients and weigh other options," said Malaz Boustani, from the US-based Regenstrief Institute.

"Physicians should review all the anticholinergic medications - including over-the-counter drugs - that patients of all ages are taking and determine safe ways to take individuals off anticholinergic medications in the interest of preserving brain health," Boustani said.

--IANS

rt/ksk/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2018 | 4:12 PM IST

Next Story